Trial lecture and disputation October 27-28th
Kristine Gulliksrud
Siv. ing. Kristine Gulliksrud from Einar Rofstad's group at the Department of Radiation Biology at the Institute for Cancer Research will give her trial lectures on Thursday October 27th. The lecture over the subject of her own choice - "Assessment of tumor pH by magnetic resonance spectroscopy and imaging" starts at 14:15. The given subject is "Therapeutic approaches for dealing with the hypoxia problem", and this lecture begins at 15:15. Both trial lectures take place in the Auditorium in the Research Therapy Building at the OUS-Radiumhospitalet, Montebello. She will defend her PhD thesis - entitled "DCE-MRI in assessment of the microenvironment and aggressiveness of human tumor xenografts" the following day, on Friday October 28th at 10:15. The disputation takes place in the "Lille Fysiske auditorium, Fysikkbygningen" at the University of Oslo.
Chauhan SK, Dunn C, Andresen NK, Røssevold AH, Skorstad G, Sike A, Gilje B, Raj SX, Huse K, Naume B, Kyte JA(2024) Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation NPJ Breast Cancer, 10(1), 30 DOI 10.1038/s41523-024-00638-2, PubMed 38653982
Miceli R, Eriksson H, Lo Russo G, Alfieri S, Moksnes Bjaanæs M, Pietrantonio F, De Cecco L, Prelaj A, Proto C, Franzén J, McDonnell D, Berenguer Pina JJ, Beninato T, Mazzeo L, Giannatempo P, Verzoni E, Crown J, Helland Å, Eustace A(2024) Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study Acta Oncol, 63, 213-219 DOI 10.2340/1651-226X.2024.24179, PubMed 38647024
Fackler MJ, Pleas M, Li Y, Soni A, Xing D, Cope L, Ali S, Van Le Q, Van Nguyen C, Pham HT, Duong LM, Vanden Berg E, Wadee R, Michelow P, Chen WC, Joffe M, Fjeldbo CS, Lyng H, Sukumar S(2024) Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries Clin Epigenetics, 16(1), 56 DOI 10.1186/s13148-024-01669-z, PubMed 38643219